摘要:
La présente invention concerne une composition immunogène comprenant une phase aqueuse continue et une phase dispersée sous forme de gouttelettes et comprenant : - un lipide amphiphile, - un lipide solubilisant comprenant au moins un glycéride d'acide gras, - un co-tensioactif comprenant au moins une chaîne composée de motifs d'oxyde d'alkylène, - un tensioactif porteur d'un antigène de formule (I) suivante : (L 1 -X 1 -H 1 -Y 1 ) v -G-Z 1 -Ag (I), son procédé de préparation et ses utilisations, notamment pour la production d'anticorps, en tant que médicament ou dans une méthode d'immunisation.
摘要:
A microbial adherence inhibitor in the form of fowl egg antibodies is disclosed, along with the method of making it and methods of using it. The inhibitor functions by substantially preventing the attachment of adherence of colony-forming immunogens in the respiratory tracts of host animals and humans. The inhibitor is made by inoculating female birds with the immunogen, harvesting the eggs which contain antibodies to the immunogen, and separating the yolk and albumin from the shells of the eggs. The yolk and albumin contents are administered to animals or human by distributing the contents directly or introducing the contents entrained in air. The adherence inhibiting material can be formulated for use in a variety of ways such as an oral spray or a nasal spray. These formulations can be effective to prevent or reduce respiratory illnesses in animals and humans.
摘要:
The present invention provides a method of preparing an antibody-containing milk or egg product for use in preventing and/or treating of a non-infectious medical condition. The invention also provides non-systemic modes of administering pharmaceutical compositions including the antibody-containing milk or egg products, including to the GI tract.
摘要:
A method for increasing antigen-specific antibody titer in an egg by administering a cyclooxygenase inhibitor to an egg-laying animal prior to exposure to the antigen.
摘要:
Compositions, food products or beverages for ameliorating the syptoms of celiac disease or gluten sensitive enteropathy comprising egg yolk antibodies against gluten, including gliadin, high molecular glutenin, low molecular glutenin and mixtures of the three peptides. The antibodies may be produced by immunizing egg laying fowl with immunogenic preparations of gluten and harvesting the eggs and egg yolks.
摘要:
Methods and compositions are disclosed for the dietary modulation of the immune system and gut microbial response in animals. Applicant has identified that oral administration of a supplemental spray dried plasma purified from animal serum can modulate serum IgG levels for treatment in such things as diminished immune capacity, intestinal microbial balance, autoimmune disorders, potentiation of vaccination protocols, and improvement of overall health and weight gain in animals, including humans.
摘要:
A microbial adherence inhibitor in the form of fowl egg antibodies is disclosed, along with the method of making it and methods of using it. The inhibitor functions by substantially preventing the attachment of adherence of colony-forming immunogens in the respiratory tracts of host animals and humans. The inhibitor is made by inoculating female birds with the immunogen, harvesting the eggs which contain antibodies to the immunogen, and separating the yolk and albumin from the shells of the eggs. The yolk and albumin contents are administered to animals or human by distributing the contents directly or introducing the contents entrained in air.
摘要:
The invention features compositions containing avian-derived transgenic nonavian antibodies and methods of recovering the compositions from transgenic avian eggs. Chromatographic techniques permit the purification of non-avain proteins produced in an avain tissue from contaminating avian tissue components for administration to humans.
摘要:
Human antibodies are produced in transgenic chickens having functional genetic components of the human immune system stably integrated in the genome. Techniques are described to integrate unrearranged human heavy and light chain immunoglobulin loci into the genome of the transgenic chicken. The functional description of the endogenous immunoglobulin loci yields an animal whose antibody repertoire in response to antigen is fully human. In the preferred embodiment, the human immunoglobulin locus is at least as large as the native human locus and exhibits functional class switching to yield IgG isotype antibodies. In addition to monoclonal antibodies secreted from immortalized B cell populations, polyclonal antibodies may be obtained from eggs laid by the transgenic chickens of the invention.